s(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid has been researched along with Hypersensitivity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berkenkopf, JW; Chang, JY; Grimes, D; Heaslip, RJ; Kreft, AF; Lewis, AJ; Musser, JH; Weichman, BM | 1 |
Banker, AL; Demerson, CA; Failli, AA; Gray, W; Kreft, AF; Kubrak, DM; Musser, JH; Nelson, JA; Shah, US; Steffan, R | 1 |
2 other study(ies) available for s(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid and Hypersensitivity
Article | Year |
---|---|
WY-50, 295 tromethamine: an orally active 5-lipoxygenase inhibitor with anti-allergic activity.
Topics: Administration, Oral; Animals; Antigens; Bronchoconstriction; Guinea Pigs; Hypersensitivity; Leukotrienes; Lipoxygenase Inhibitors; Muscle Contraction; Naphthaleneacetic Acids; Quinolines; SRS-A; Trachea | 1991 |
Conversion of a cyclooxygenase (CO) inhibitor into a 5-lipoxygenase (LO) inhibitor: a general route to novel orally active anti-inflammatory and anti-allergy drugs.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Eicosanoids; Guinea Pigs; Hypersensitivity; Leukotrienes; Lipoxygenase Inhibitors; Muscle Contraction; Naphthaleneacetic Acids; Quinolines; SRS-A; Trachea | 1991 |